97 related articles for article (PubMed ID: 10200338)
1. Effect of doxorubicin on wild-type and deoxyadenosine-resistant mouse leukemia L1210 cells.
He AW; Cory JG
Int J Oncol; 1999 May; 14(5):891-5. PubMed ID: 10200338
[TBL] [Abstract][Full Text] [Related]
2. Effect of ionizing radiation on wild-type and mutant mouse leukemia L1210 cells.
He AW; Cory JG
Oncol Res; 1998; 10(9):455-64. PubMed ID: 10223621
[TBL] [Abstract][Full Text] [Related]
3. Enhanced roscovitine-induced apoptosis is mediated by a caspase-3-like activity in deoxyadenosine-resistant mouse leukemia L1210 cells.
Somerville L; Cory JG
Anticancer Res; 2000; 20(5B):3347-55. PubMed ID: 11131634
[TBL] [Abstract][Full Text] [Related]
4. Increased sensitivity to sodium salicylate-induced apoptosis in drug-resistant leukemia L1210 cells.
Hall JG; Cory AH; Hickerson DH; Cory JG
Anticancer Res; 2001; 21(1A):173-80. PubMed ID: 11299731
[TBL] [Abstract][Full Text] [Related]
5. Altered sensitivity of deoxyadenosine-resistant mouse leukemia L1210 cells to various kinase inhibitors.
Somerville L; Cory JG
Anticancer Res; 1999; 19(2A):1021-6. PubMed ID: 10368649
[TBL] [Abstract][Full Text] [Related]
6. Altered steady-state levels of the messenger RNAs for c-myc and p53 in L1210 cell lines resistant to deoxyadenosine.
Cory JG; Cory AH; Long SD; Carter GL; Johnson CE
Cancer Res; 1992 Apr; 52(7):2000-3. PubMed ID: 1551129
[TBL] [Abstract][Full Text] [Related]
7. Augmentation of apoptosis responses in p53-deficient L1210 cells by compounds directed at blocking NFkappaB activation.
Cory AH; Cory JG
Anticancer Res; 2001; 21(6A):3807-11. PubMed ID: 11911251
[TBL] [Abstract][Full Text] [Related]
8. Deoxyadenosine-resistant mouse leukemia L1210 cell lines with alterations in early response genes and p53.
Cory JG; He AW; Cory AH
Anticancer Res; 1996; 16(6B):3483-9. PubMed ID: 9042210
[TBL] [Abstract][Full Text] [Related]
9. Altered sensitivity of deoxyadenosine-resistant mouse leukemia L1210 cells to apoptosis induced by 7-hydroxystaurosporine.
Somerville L; Cory JG
Int J Oncol; 2000 Oct; 17(4):797-803. PubMed ID: 10995894
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis induced by inhibitors of nucleotide synthesis in deoxyadenosine-resistant leukemia L1210 cells that lack p53 expression.
Cory AH; Hickerson DH; Cory JG
Anticancer Res; 2000; 20(6B):4171-8. PubMed ID: 11205244
[TBL] [Abstract][Full Text] [Related]
11. Effects of PRIMA-1 on wild-type L1210 cells expressing mutant p53 and drug-resistant L1210 cells lacking expression of p53: necrosis vs. apoptosis.
Cory AH; Chen J; Cory JG
Anticancer Res; 2006; 26(2A):1289-95. PubMed ID: 16619536
[TBL] [Abstract][Full Text] [Related]
12. Cellular responses in mouse leukemia L1210 cells made resistant to deoxyadenosine.
Cory AH; Cory JG
Biochem Biophys Res Commun; 1998 Aug; 249(3):687-91. PubMed ID: 9731198
[TBL] [Abstract][Full Text] [Related]
13. p53-independent anisomycin induced G1 arrest and apoptosis in L1210 cell lines.
He AW; Cory JG
Anticancer Res; 1999; 19(1A):421-8. PubMed ID: 10226577
[TBL] [Abstract][Full Text] [Related]
14. Phenolic compounds, sodium salicylate and related compounds, as inhibitors of tumor cell growth and inducers of apoptosis in mouse leukemia L1210 cells.
Cory AH; Cory JG
In Vivo; 2005; 19(1):31-5. PubMed ID: 15796154
[TBL] [Abstract][Full Text] [Related]
15. Lactacystin, a proteasome inhibitor, potentiates the apoptotic effect of parthenolide, an inhibitor of NFkappaB activation, on drug-resistant mouse leukemia L1210 cells.
Cory AH; Cory JG
Anticancer Res; 2002; 22(6C):3805-9. PubMed ID: 12552998
[TBL] [Abstract][Full Text] [Related]
16. Bis(2-hydroxybenzylidene)acetone, a potent inducer of the phase 2 response, causes apoptosis in mouse leukemia cells through a p53-independent, caspase-mediated pathway.
Dinkova-Kostova AT; Cory AH; Bozak RE; Hicks RJ; Cory JG
Cancer Lett; 2007 Jan; 245(1-2):341-9. PubMed ID: 16517063
[TBL] [Abstract][Full Text] [Related]
17. Mouse leukemia L1210 cells selected for resistance to the ribonucleotide reductase inhibitor, 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone show altered response to DNA damaging agents.
Crenshaw TR; Cory JG
Int J Oncol; 1999 Sep; 15(3):487-90. PubMed ID: 10427129
[TBL] [Abstract][Full Text] [Related]
18. Cell-cycle associated transcriptional regulation of ribonucleotide reductase in L1210 leukemia cells and drug-resistant variants.
Johnson CE; Hughes K; Cory JG
Cancer Commun; 1991; 3(10-11):341-9. PubMed ID: 1760249
[TBL] [Abstract][Full Text] [Related]
19. Blockage of cyclin cdk's, PKC and phosphoinositol 3-kinase pathways leads to augmentation of apoptosis in drug-resistant leukemia cells: evidence for interactive effects of flavopiridol, LY 294002, roscovitine,wortmannin and UCN-01.
Cory AH; Somerville L; Cory JG
Anticancer Res; 2005; 25(1A):101-6. PubMed ID: 15816525
[TBL] [Abstract][Full Text] [Related]
20. An abnormality in the p53 pathway following gamma-irradiation in many wild-type p53 human melanoma lines.
Bae I; Smith ML; Sheikh MS; Zhan Q; Scudiero DA; Friend SH; O'Connor PM; Fornace AJ
Cancer Res; 1996 Feb; 56(4):840-7. PubMed ID: 8631022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
